Ligand Pharm
(LGND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,719 | -117,880 | -100,150 | -37,313 | -64,172 |
| Depreciation Amortization | 14,986 | 4,510 | 7,130 | 6,682 | 2,687 |
| Accounts receivable | -1,657 | N/A | N/A | N/A | N/A |
| Other Working Capital | -8,596 | -1,530 | 12,010 | -4,025 | 1,342 |
| Other Operating Activity | 10,336 | 48,260 | 67,650 | 1,354 | 22,269 |
| Operating Cash Flow | $-59,650 | $-66,640 | $-13,360 | $-33,302 | $-37,874 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,789 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,385 | -2,270 | -4,160 | -399 | -175 |
| Net Acquisitions | N/A | -5,750 | 0 | 0 | -822 |
| Other Investing Activity | -43,190 | -20,590 | 8,470 | 7,897 | 29,637 |
| Investing Cash Flow | $-25,786 | $-28,610 | $4,310 | $7,498 | $28,640 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 63,027 | N/A | N/A | N/A | N/A |
| Debt Repayment | -3,381 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 22,349 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 543 | 65,810 | 36,460 | 44,671 | 17,568 |
| Financing Cash Flow | $82,538 | $65,810 | $36,460 | $44,671 | $17,568 |
| Beginning Cash Position | 32,801 | 62,250 | 34,830 | 15,963 | 7,628 |
| End Cash Position | 29,903 | 32,800 | 62,250 | 34,830 | 15,962 |
| Net Cash Flow | $-2,898 | $-29,450 | $27,420 | $18,867 | $8,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,650 | -66,640 | -13,360 | -33,302 | -37,874 |
| Capital Expenditure | -2,385 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -62,035 | -66,640 | -13,360 | -33,302 | -37,874 |